At KLOWs fixed ratio, delivering 2 mg of TB-4 would require 16 mg total KLOW: 10 mg GHK-Cu and 2 mg each of BPC-157, TB-4, and KPV an absurdly high, potentially dangerous amount of GHK-Cu
Think of it as a biological messenger
Sample BPC-157 + TB-500 Dosing Protocol Researchers using BPC-157 and TB-500 capsules may reference the below dosing protocol
CPT Code 96372 is designated for reporting a single therapeutic, prophylactic, or diagnostic injection, either subcutaneously (under the skin) or intramuscularly (into the muscle)
Local injection near injury sites allows concentrated delivery to specific areas
The storage requirements are different for each phase, and the consequences of getting them wrong are different too